OpGen: Funding, Investors & Team (Oct 2026)
OpGen is a company in the field of precision medicine that utilizes molecular diagnostics and bioinformatics to fight against infectious diseases. Through its subsidiaries Curetis and Ares Genetics, OpGen creates and sells molecular microbiology solutions to give clinicians quicker and more actionable information about life-threatening infections, ultimately leading to better patient outcomes. The company's diagnostic methods for infectious diseases include highly multiplexed molecular panels and next-generation sequencing paired with advanced bioinformatics and artificial intelligence to address the global challenge of antimicrobial resistance. By combining these technologies, OpGen offers rapid molecular diagnostic products and services that significantly improve patient care by using precision medicine to guide antibiotic treatment selection, enhance antibiotic stewardship, reduce the spread of drug-resistant microorganisms, and optimize the treatment of life-threatening infections. Founded in 2002 by David Schwartz, OpGen is located in Rockville, Maryland.
OpGen has raised $10.5M across 2 funding rounds on record, the most recent an undisclosed round of $3.0M announced in Mar 2024.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
OpGen Company Profile and Key Stats
Latest funding round on record: Mar 2024.
OpGen Funding Rounds
OpGen raised $7.5M in an undisclosed round announced in Jan 2023.
1.2 years later, an undisclosed round of $3.0M was announced in Mar 2024.
OpGen Founders and Leadership Team
Contact details for the OpGen team: 1 of 2 have an email address on file.
Start 14-day free trial →OpGen Funding Compared to Other Biotechnology Startups
OpGen's latest round of $3.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like OpGen in Biotechnology and Rockville
Companies Similar to OpGen
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
OpGen Funding FAQs
What does OpGen do?
OpGen is a company in the field of precision medicine that utilizes molecular diagnostics and bioinformatics to fight against infectious diseases. Through its subsidiaries Curetis and Ares Genetics, OpGen creates and sells molecular microbiology solutions to give clinicians quicker and more actionable information about life-threatening infections, ultimately leading to better patient outcomes. The company's diagnostic methods for infectious diseases include highly multiplexed molecular panels and next-generation sequencing paired with advanced bioinformatics and artificial intelligence to address the global challenge of antimicrobial resistance. By combining these technologies, OpGen offers rapid molecular diagnostic products and services that significantly improve patient care by using precision medicine to guide antibiotic treatment selection, enhance antibiotic stewardship, reduce the spread of drug-resistant microorganisms, and optimize the treatment of life-threatening infections. Founded in 2002 by David Schwartz, OpGen is located in Rockville, Maryland.
How much funding has OpGen raised?
OpGen has raised $10.5M across 2 rounds on record. The most recent is an undisclosed round of $3.0M announced in Mar 2024.
When did OpGen last raise funding?
OpGen's most recent funding round on record is an undisclosed round of $3.0M, announced in Mar 2024.
Who founded OpGen?
FundedIQ lists Noel Doheny (Founder) at OpGen.
Who is the CEO of OpGen?
Oliver Schacht is listed as CEO at OpGen.
Where is OpGen headquartered?
OpGen is based in Rockville, Maryland, United States.
How many employees does OpGen have?
OpGen is in the 101-250 employee band.
How does OpGen's funding compare to other Biotechnology startups?
OpGen's latest round of $3.0M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's OpGen Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for OpGen is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.